SYRMA Q4 FY26 Guidance vs Delivery (SYRMA Management Mirror)

Revenue & Growth

Management targets 30-35% revenue growth for FY27 to ~6,000 crores in the Mar'26 Qtr, upgrading expectations from the 30% growth guided in the Dec'25 Qtr, following a reaffirmed FY26 organic growth target of ~30% during the Sep'25 Qtr. Exports are expected to cross 1,500 crores in FY27 (growing 25-30%), raised from the >1,000-1,100 crores projection in the Dec'25 Qtr and the 1,000 crore target set in the Sep'25 Qtr. The MedTech/Healthcare business is projected to exceed 500 crores in FY27, while the consumer segment is consciously capped at ~30% of revenue (~1,500-1,600 crores), consistent with the 31-32% mix guided in the Dec'25 Qtr. [Status: Upgraded]